Coursera Flash Sale
40% Off Coursera Plus for 3 Months!
Grab it
Learn about advanced therapeutic strategies for targeting the AKT pathway in cancer treatment through this medical grand rounds presentation by Dr. Ramon Parsons from Yale Cancer Center, exploring current challenges and emerging tools for more effective AKT inhibition in oncology, discussing the molecular mechanisms underlying AKT signaling in tumor development and progression, examining existing AKT inhibitors and their limitations in clinical applications, and presenting novel approaches and technologies being developed to improve specificity and efficacy of AKT-targeted therapies for various cancer types.
